The Trauma INtramuscular Tranexamic Acid Clinical Trial
Status:
Completed
Trial end date:
2020-02-12
Target enrollment:
Participant gender:
Summary
Intramuscular injection of tranexamic acid (TXA) would increase its use in situations where
administration of intravenous drugs is difficult. The investigators aim to assess the
population pharmacokinetics of intramuscular TXA in trauma patients.
Primary endpoint: Serum TXA concentrations over time. Secondary endpoints: Local reactions at
injection sites and adverse events
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Barts & The London NHS Trust JP Moulton Charitable Foundation St George's University Hospitals NHS Foundation Trust University of Versailles